Longitudinal quality of life study in patients with metastatic gastric cancer
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 29 (11) , 1113-1124
- https://doi.org/10.1016/s0399-8320(05)82175-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803Journal of Clinical Oncology, 2004
- Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerEuropean Journal Of Cancer, 2004
- Measuring quality of life: Is quality of life determined by expectations or experience?BMJ, 2001
- Methodological approaches for assessing response shift in longitudinal health-related quality-of-life researchSocial Science & Medicine, 1999
- 1180: First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal Of Cancer, 1997
- Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experienceEuropean Journal Of Cancer, 1997
- Critical review of the international assessments of health-related quality of lifeQuality of Life Research, 1993
- Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnosesQuality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989